June 22, 2018
The Food and Drug Administration has approved two generic versions of an innovative drug to treat opioid addiction, increasing available treatment options for Americans fighting addiction. The move underscores a growing realization among policymakers, regulators and industry: to address the opioid crisis, innovative solutions must be readily available.
June 1, 2018
As the global cancer community convenes for the annual meeting of the American Society of Clinical Oncology, one question looms large: What will President Donald Trump’s blueprint to lower drug prices mean for patient access? Especially for cancer patients, who may take several medications or live on a fixed income?
May 17, 2018
Heart patients in Europe have something to celebrate. This week, the European Commission approved a groundbreaking new drug, evolocumab, to prevent heart attack and stroke for patients who have already survived a cardiac event.
May 15, 2018
New research suggests that President Donald Trump, U.S. senators and the country’s physicians may agree on at least one thing: the federal 340B drug pricing program deserves more scrutiny. Designed to encourage care for indigent and underinsured patients, the program has ballooned into a revenue stream for growing hospital systems.
May 11, 2018
This month, patients with Huntington’s disease are asking for what worked for patients with ALS and other debilitating diseases–parity to accessing Medicare benefits. The request is a focal point for May’s Huntington’s Disease Awareness Month.
May 4, 2018
Patient advocacy organizations know the power of the patient voice when it comes to accessing medicine.
April 13, 2018
Nearly 4 million babies are born each year in the United States. Yet physicians can have remarkably limited data about treating mothers’ health conditions during pregnancy.
April 10, 2018
Could a recent memorandum from the U.S. Patent and Trademark Office impact treatment options for patients? Washington, DC’s nonprofit Bipartisan Policy Center says: Yes.
March 29, 2018
Patients overpay for their prescriptions 23 percent of the time, a recently released study from the University of Southern California found. What’s worse – some pharmacists can’t tell patients when they’re paying too much.
March 27, 2018
How accessible is your health care? It all depends upon where you live, as a new report from the European Federation of Crohn's & Ulcerative Colitis Associations confirms.
